Campoy Carlos 4
4 · CytomX Therapeutics, Inc. · Filed Jun 8, 2021
Insider Transaction Report
Form 4
Campoy Carlos
Chief Financial Officer
Transactions
- Award
Common Stock
2021-05-31$6.09/sh+3,320$20,206→ 6,421 total
Footnotes (1)
- [F1]3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).